BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis
Recruiting · NCT07417904 · Interventional (participants receive a specific treatment) · Lead sponsor: Howard University
View the official record on ClinicalTrials.gov →Interventions studied
BRAVE (Behavioral Response Against Violence Engagement)Treatment As Usual (TAU)
What this trial is about
This study evaluates the feasibility and acceptability of BRAVE, a manualized cognitive behavioral therapy (CBT)-based intervention designed to address dynamic risk factors for violence among young adults with early psychosis. Using a stepped-wedge randomized design, all participants will receive treatment as usual followed by the BRAVE intervention. The study will also explore changes in violence-related behaviors and treatment engagement over time.
Who can take part
Age range
16 Years to 30 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Young adults aged 16-30 years
- Diagnosis of early psychosis
- Currently receiving outpatient care through an early psychosis clinic
- Psychiatrically stable and deemed appropriate for participation by a treating clinician
- Able and willing to provide informed consent
Exclusion criteria
- Unable to provide informed consent
- Not fluent in English
- History of antisocial behavior, as assessed at baseline
- Immediate risk requiring a higher level of care
Where it is running
2 locations listed across 1 US state.
- Howard University Hospital - Washington D.C., District of Columbia, United States
- Howard University Hospital - Washington D.C., District of Columbia, United States